サマリー

低濃度アトロピンの世界市場 2024-2028
低濃度アトロピン市場は2023-2028年に10億3997万米ドルで成長し、予測期間中のCAGRは18.81%で加速すると予測されます。当レポートでは、低濃度アトロピン市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析などを掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。近視の有病率の増加、視力ケアに関する意識の高まり、高齢化社会における視力矯正需要の高まりが市場を牽引しています。
Technavio社の低濃度アトロピン市場は以下のように分類されます：
タイプ別
- 硫酸アトロピン0.01
- 硫酸アトロピン0.025
- 硫酸アトロピン0.05
用途別
- 小児
- 成人
地域別
- アジア
- 北米
- ヨーロッパ
- その他の地域（ROW）
本調査では、今後数年間の低濃度アトロピン市場の成長を促進する主な理由の一つとして、市場ベンダーによる臨床試験数の増加を挙げている。また、近視研究への資金提供への注目の高まりや、市場ベンダーによるパートナーシップの増加は、市場の大きな需要につながるだろう。
この調査レポートは、低濃度アトロピン市場を調査・分析し、以下のてこ入れを行った：
- 低濃度アトロピン市場のサイジング
- 低濃度アトロピン市場予測
- 低濃度アトロピン市場産業分析
本レポートでは、低濃度アトロピン市場の主要ベンダー（AdvaCare Pharma、Aurolab、Bausch Lomb Corp、ENTOD INTERNATIONAL、Eyenovia Inc.、Gmt Pharma、Grevis Pharmaceuticals Pvt.Ltd.、ISKON REMEDIES and GMT、Jawa Pharmaceuticals India Pvt.Ltd.、Medizia Biotech、OSRX Inc.、Raymed Pharmaceutical Ltd.、参天製薬株式会社、Sydnexis Inc.Ltd.、Sydnexis Inc.、Tache Pharmacy、Taiwan Biotech Co.Ltd.、Vyluma、Aspire Pharma Ltd.などである。また、低濃度アトロピン市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/low-concentration-atropine-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market by Geography
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global low-concentration atropine market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global low-concentration atropine market 2018 - 2022 ($ million)
o 4.2 Type Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
o 4.3 Application Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028
o Exhibit 34: Chart on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
o 6.4 Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028
o Exhibit 38: Chart on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
o 6.5 Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028
o Exhibit 42: Chart on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Type
o Exhibit 46: Market opportunity by Type ($ million)
o Exhibit 47: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 48: Chart on Application - Market share 2023-2028 (%)
o Exhibit 49: Data Table on Application - Market share 2023-2028 (%)
o 7.2 Comparison by Application
o Exhibit 50: Chart on Comparison by Application
o Exhibit 51: Data Table on Comparison by Application
o 7.3 Child - Market size and forecast 2023-2028
o Exhibit 52: Chart on Child - Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Child - Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Child - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Child - Year-over-year growth 2023-2028 (%)
o 7.4 Adult - Market size and forecast 2023-2028
o Exhibit 56: Chart on Adult - Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Adult - Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Adult - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Adult - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by Application
o Exhibit 60: Market opportunity by Application ($ million)
o Exhibit 61: Data Table on Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share by geography 2023-2028 (%)
o Exhibit 64: Data Table on Market share by geography 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 Asia - Market size and forecast 2023-2028
o Exhibit 67: Chart on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 68: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
o Exhibit 69: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.4 North America - Market size and forecast 2023-2028
o Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.5 Europe - Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 China - Market size and forecast 2023-2028
o Exhibit 87: Chart on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on China - Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.9 Germany - Market size and forecast 2023-2028
o Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.10 Canada - Market size and forecast 2023-2028
o Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.11 Japan - Market size and forecast 2023-2028
o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity by geography
o Exhibit 103: Market opportunity by geography ($ million)
o Exhibit 104: Data Tables on Market opportunity by geography ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 AdvaCare Pharma
o Exhibit 111: AdvaCare Pharma - Overview
o Exhibit 112: AdvaCare Pharma - Product / Service
o Exhibit 113: AdvaCare Pharma - Key offerings
o 12.4 Bausch Lomb Corp.
o Exhibit 114: Bausch Lomb Corp. - Overview
o Exhibit 115: Bausch Lomb Corp. - Business segments
o Exhibit 116: Bausch Lomb Corp. - Key news
o Exhibit 117: Bausch Lomb Corp. - Key offerings
o Exhibit 118: Bausch Lomb Corp. - Segment focus
o 12.5 ENTOD INTERNATIONAL
o Exhibit 119: ENTOD INTERNATIONAL - Overview
o Exhibit 120: ENTOD INTERNATIONAL - Key offerings
o 12.6 Eyenovia Inc.
o Exhibit 121: Eyenovia Inc. - Overview
o Exhibit 122: Eyenovia Inc. - Key offerings
o 12.7 Gmt Pharma
o Exhibit 123: Gmt Pharma - Overview
o Exhibit 124: Gmt Pharma - Product / Service
o Exhibit 125: Gmt Pharma - Key offerings
o 12.8 ISKON REMEDIES and GMT
o Exhibit 126: ISKON REMEDIES and GMT - Overview
o Exhibit 127: ISKON REMEDIES and GMT - Product / Service
o Exhibit 128: ISKON REMEDIES and GMT - Key offerings
o 12.9 Jawa Pharmaceuticals INDIA Pvt. Ltd.
o Exhibit 129: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Overview
o Exhibit 130: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Product / Service
o Exhibit 131: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Key offerings
o 12.10 Medizia Biotech
o Exhibit 132: Medizia Biotech - Overview
o Exhibit 133: Medizia Biotech - Product / Service
o Exhibit 134: Medizia Biotech - Key offerings
o 12.11 OSRX Inc.
o Exhibit 135: OSRX Inc. - Overview
o Exhibit 136: OSRX Inc. - Product / Service
o Exhibit 137: OSRX Inc. - Key offerings
o 12.12 Raymed Pharmaceutical Ltd.
o Exhibit 138: Raymed Pharmaceutical Ltd. - Overview
o Exhibit 139: Raymed Pharmaceutical Ltd. - Product / Service
o Exhibit 140: Raymed Pharmaceutical Ltd. - Key offerings
o 12.13 Santen Pharmaceutical Co. Ltd.
o Exhibit 141: Santen Pharmaceutical Co. Ltd. - Overview
o Exhibit 142: Santen Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 143: Santen Pharmaceutical Co. Ltd. - Key offerings
o 12.14 Sydnexis Inc.
o Exhibit 144: Sydnexis Inc. - Overview
o Exhibit 145: Sydnexis Inc. - Product / Service
o Exhibit 146: Sydnexis Inc. - Key offerings
o 12.15 Tache Pharmacy
o Exhibit 147: Tache Pharmacy - Overview
o Exhibit 148: Tache Pharmacy - Product / Service
o Exhibit 149: Tache Pharmacy - Key offerings
o 12.16 Taiwan Biotech Co.,Ltd
o Exhibit 150: Taiwan Biotech Co.,Ltd - Overview
o Exhibit 151: Taiwan Biotech Co.,Ltd - Product / Service
o Exhibit 152: Taiwan Biotech Co.,Ltd - Key offerings
o 12.17 Vyluma
o Exhibit 153: Vyluma - Overview
o Exhibit 154: Vyluma - Product / Service
o Exhibit 155: Vyluma - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 156: Inclusions checklist
o Exhibit 157: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 158: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 159: Research methodology
o Exhibit 160: Validation techniques employed for market sizing
o Exhibit 161: Information sources
o 13.5 List of abbreviations
o Exhibit 162: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global low-concentration atropine market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Atropine sulfate 0.01 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Atropine sulfate 0.01 percentage - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Atropine sulfate 0.025 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Atropine sulfate 0.025 percentage - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Atropine sulfate 0.05 percentage - Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Atropine sulfate 0.05 percentage - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Data Table on Market opportunity by Type ($ million)
Exhibits48: Chart on Application - Market share 2023-2028 (%)
Exhibits49: Data Table on Application - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Application
Exhibits51: Data Table on Comparison by Application
Exhibits52: Chart on Child - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Child - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Child - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Child - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Adult - Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Adult - Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Adult - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Adult - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Application ($ million)
Exhibits61: Data Table on Market opportunity by Application ($ million)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share by geography 2023-2028 (%)
Exhibits64: Data Table on Market share by geography 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity by geography ($ million)
Exhibits104: Data Tables on Market opportunity by geography ($ million)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AdvaCare Pharma - Overview
Exhibits112: AdvaCare Pharma - Product / Service
Exhibits113: AdvaCare Pharma - Key offerings
Exhibits114: Bausch Lomb Corp. - Overview
Exhibits115: Bausch Lomb Corp. - Business segments
Exhibits116: Bausch Lomb Corp. - Key news
Exhibits117: Bausch Lomb Corp. - Key offerings
Exhibits118: Bausch Lomb Corp. - Segment focus
Exhibits119: ENTOD INTERNATIONAL - Overview
Exhibits120: ENTOD INTERNATIONAL - Key offerings
Exhibits121: Eyenovia Inc. - Overview
Exhibits122: Eyenovia Inc. - Key offerings
Exhibits123: Gmt Pharma - Overview
Exhibits124: Gmt Pharma - Product / Service
Exhibits125: Gmt Pharma - Key offerings
Exhibits126: ISKON REMEDIES and GMT - Overview
Exhibits127: ISKON REMEDIES and GMT - Product / Service
Exhibits128: ISKON REMEDIES and GMT - Key offerings
Exhibits129: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Overview
Exhibits130: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Product / Service
Exhibits131: Jawa Pharmaceuticals INDIA Pvt. Ltd. - Key offerings
Exhibits132: Medizia Biotech - Overview
Exhibits133: Medizia Biotech - Product / Service
Exhibits134: Medizia Biotech - Key offerings
Exhibits135: OSRX Inc. - Overview
Exhibits136: OSRX Inc. - Product / Service
Exhibits137: OSRX Inc. - Key offerings
Exhibits138: Raymed Pharmaceutical Ltd. - Overview
Exhibits139: Raymed Pharmaceutical Ltd. - Product / Service
Exhibits140: Raymed Pharmaceutical Ltd. - Key offerings
Exhibits141: Santen Pharmaceutical Co. Ltd. - Overview
Exhibits142: Santen Pharmaceutical Co. Ltd. - Product / Service
Exhibits143: Santen Pharmaceutical Co. Ltd. - Key offerings
Exhibits144: Sydnexis Inc. - Overview
Exhibits145: Sydnexis Inc. - Product / Service
Exhibits146: Sydnexis Inc. - Key offerings
Exhibits147: Tache Pharmacy - Overview
Exhibits148: Tache Pharmacy - Product / Service
Exhibits149: Tache Pharmacy - Key offerings
Exhibits150: Taiwan Biotech Co.,Ltd - Overview
Exhibits151: Taiwan Biotech Co.,Ltd - Product / Service
Exhibits152: Taiwan Biotech Co.,Ltd - Key offerings
Exhibits153: Vyluma - Overview
Exhibits154: Vyluma - Product / Service
Exhibits155: Vyluma - Key offerings
Exhibits156: Inclusions checklist
Exhibits157: Exclusions checklist
Exhibits158: Currency conversion rates for US$
Exhibits159: Research methodology
Exhibits160: Validation techniques employed for market sizing
Exhibits161: Information sources
Exhibits162: List of abbreviations